Skip Navigation LinksHome > May 2006 - Volume 60 - Issue 5 > A Neutrophil Elastase Inhibitor, Sivelestat, Improves Leukoc...
Journal of Trauma-Injury Infection & Critical Care:
doi: 10.1097/01.ta.0000217271.25809.a0
Original Articles

A Neutrophil Elastase Inhibitor, Sivelestat, Improves Leukocyte Deformability in Patients With Acute Lung Injury

Inoue, Yoshiaki MD; Tanaka, Hiroshi MD, PhD; Ogura, Hiroshi MD, PhD; Ukai, Isao MD; Fujita, Kieko BS; Hosotsubo, Hideo BS; Shimazu, Takeshi MD, PhD; Sugimoto, Hisashi MD

Collapse Box

Abstract

Background: The objective of this study was to evaluate whether the neutrophil elastase (NE) inhibitor, sivelestat, improves leukocyte deformability and pulmonary function in patients with acute lung injury (ALI).

Patients and Methods: Twenty-four patients with systemic inflammatory response syndrome (SIRS) were divided into two groups: those with ALI (ALI group, n = 14), and those without ALI (non-ALI group, n = 10). Within 72 hours after the diagnosis, we measured the total leukocyte count (TLC), C-reactive protein (CRP) level, NE concentration, APACHE II score, Goris multiple organ failure (MOF) index, respiratory index (RI), lung injury score (LIS), and oxygenation index (P/F ratio). Leukocyte deformability was examined with a microchannel array etched on a single-crystal silicon tip that simulates the microvasculature. The number of obstructed microchannels (NOM) because of stiffened neutrophils and transit time (TT), defined as the time needed for 100 μL of whole blood to pass through the microchannels, were determined.

We then administered sivelestat (4.8 mg/kg/d) to nine ALI patients (sivelestat group) for 5 days and compared with seven ALI patients treated previously without sivelestat (conventional group). The factors described above were measured before and 5 days after treatment.

Results: There were no significant differences in age, TLC, CRP, APACHE II score, and MOF index between ALI and non-ALI group. RI and LIS were higher and the P/F ratio was significantly lower in the ALI group than in the non-ALI group. NE concentration, NOM, and TT were significantly higher in the ALI group than in the non-ALI group (p < 0.05).

After 5 days of treatment with sivelestat, the APACHE II score, MOF index, RI, LIS, NE concentration, TT, and NOM were lower and the P/F ratio was significantly higher than baseline values and those in the conventional group (p < 0.05).

Conclusion: NE concentration and neutrophil ridigity are significantly increased in SIRS patients with ALI. Sivelestat appears to reduce NE concentration and neutrophil stiffness and improve pulmonary oxygenation in patients with ALI.

© 2006 Lippincott Williams & Wilkins, Inc.

Follow Us


Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.